BCAT2 Expression in IDC Breast Cancer subtypes: A Weighted Feature-Based Approach to Identify and Rank Associated...

Area of Science:

• Oncology
• Metabolic pathways
• Gene expression analysis

Background:

• Breast cancer exhibits metabolic pathway dysregulation, leading to metabolite addiction crucial for tumor growth.
• Personalized treatment strategies may leverage specific gene expression or metabolite profiles.
• Human branched-chain aminotransferase (hBCAT) proteins, encoded by BCAT1 and BCAT2, are key players in cellular metabolism.

Purpose of the Study:

• To investigate the role of BCAT2 in breast cancer.
• To identify and rank genes associated with BCAT2 expression in invasive breast cancer.
• To explore the prognostic significance of BCAT2 in different breast cancer subtypes.

Main Methods:

• Utilized a weighted feature-based approach to analyze public breast cancer invasive ductal carcinoma patient datasets.
• Identified and ranked genes associated with BCAT2 expression.
• Visualized BCAT2 gene expression patterns across various breast cancer subtypes.

Main Results:

• Lower BCAT2 expression correlated with a worse prognosis in breast cancer patients.
• BCAT2 gene expression levels were ranked and visualized, indicating potential associations with risk.
• Distinct BCAT2 expression patterns were observed across different breast cancer subtypes.

Conclusions:

• BCAT2 expression serves as a potential prognostic biomarker in breast cancer.
• Findings suggest BCAT2 dysregulation may be linked to breast cancer risk and progression.
• Further experimental investigation into BCAT2's role is warranted for therapeutic development.